Wimmer Associates 1’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Wimmer Associates 1's LLY Position: Q1 2026 in Review
Wimmer Associates 1 increased its Eli Lilly (LLY) stake by 3.7% in Q1 2026, buying an estimated $86.2K and bringing the position to 2,395 shares worth $2.2M. The position accounts for 1.08% of the portfolio, ranked #25.
Wimmer Associates 1 first reported a position in LLY in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.48M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Wimmer Associates 1 held 2,395 shares of Eli Lilly worth $2.2M as of Q1 2026.
- Wimmer Associates 1 bought 85 Eli Lilly shares in Q1 2026, an estimated $86.2K.
- Eli Lilly made up 1.08% of Wimmer Associates 1's portfolio in Q1 2026, its #25 holding.
- Wimmer Associates 1 first reported a position in Eli Lilly in Q3 2020 and has held it in 23 quarters since.
- Wimmer Associates 1's Eli Lilly position peaked at $2.48M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Wimmer Associates 1's 13F filing for Q1 2026, filed 15 May 2026.